Important note: Information in this article was accurate in 2006. The state of the art may have changed since the publication date.
Important note: Information in this article was accurate in 2006. The state of the art may have changed since the publication date.
Reuters NewMedia - December 8, 2006
The study, published on the Web site of the journal "AIDS," followed thousands of women in Africa and Asia and compared their patterns of contraceptive use to their risk of infection with HIV, the virus that causes AIDS.
"Understanding whether hormonal contraceptive use alters the risk of HIV acquisition among women is a critical public health issue," the study authors wrote.
Some 6,000 women, in Uganda, Zimbabwe and Thailand enrolled in the study were offered a choice of the most commonly prescribed forms of hormonal contraception, birth control pills or DMPA (depot-medroxyprogesterone acetate) injections, as well as condoms.
Before enrolling, the women, aged 18 to 35, were either using no hormonal contraceptives or had used them for at least three months before the study began. None were infected with HIV when they enrolled, the researchers wrote.
The participants primarily were women who sought family planning services at clinics. They were tested for HIV four to five times a year for 15 to 24 months.
By the time the study ended, 213 African women and four Thai women had tested positive for HIV. Because there were too few cases in Thailand for a valid statistical interpretation, those cases were excluded from the final analysis, they said.
When the 213 cases were considered together, researchers found no evidence that use of hormonal contraceptives increased a woman's chances of becoming infected with HIV, the study concluded.
"In summary, this large, multi-site study found no overall increased risk of HIV acquisition associated with hormonal contraceptive uses, " the study authors wrote.
However, the authors noted that their study could not rule out an increase in risk for HIV infection among those already at higher than normal risks, such as sex workers.
061208
RE061224
Copyright © 2006 - Reuters, Ltd. All rights reserved. Republication or redistribution of Reuters content is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Contact Reuters.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2006. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2006. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .